Banicka, V.; Martens, M.C.; Panzer, R.; Schrama, D.; Emmert, S.; Boeckmann, L.; Thiem, A.
Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells. Int. J. Mol. Sci. 2022, 23, 11649.
https://doi.org/10.3390/ijms231911649
AMA Style
Banicka V, Martens MC, Panzer R, Schrama D, Emmert S, Boeckmann L, Thiem A.
Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells. International Journal of Molecular Sciences. 2022; 23(19):11649.
https://doi.org/10.3390/ijms231911649
Chicago/Turabian Style
Banicka, Veronika, Marie Christine Martens, Rüdiger Panzer, David Schrama, Steffen Emmert, Lars Boeckmann, and Alexander Thiem.
2022. "Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells" International Journal of Molecular Sciences 23, no. 19: 11649.
https://doi.org/10.3390/ijms231911649
APA Style
Banicka, V., Martens, M. C., Panzer, R., Schrama, D., Emmert, S., Boeckmann, L., & Thiem, A.
(2022). Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells. International Journal of Molecular Sciences, 23(19), 11649.
https://doi.org/10.3390/ijms231911649